Delivery Order SPE2DB20D2104-SPE2DB25FMHNG

Award Date 2/6/25
Potential Completion Date 2/7/25
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,734.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,074,931 units of Carvedilol ER 40 mg capsules. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Carvedilol ER 40 mg capsules. The $1,061.36 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides worldwide logistics support to the U.S. military. The award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
This federal contract award to AmerisourceBergen Drug Corp is for the delivery of 4,566,602,374 units of the pharmaceutical product Carvedilol ER 40 mg capsules. The contract has a ceiling value of $7,220.22 and was awarded on December 3, 2024, with a completion date of December 4, 2024. The contract is a delivery order under a firm fixed-price contract type, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. This award is a part of AmerisourceBergen's...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,599.83 Firm Fixed Price delivery order is for the supply of Carvedilol ER 40 mg capsules. The contract has a completion date of September 11, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 10 mg capsules. The contract has a ceiling value of $4,346.65 and an ultimate completion date of January 27, 2025. It is a firm fixed-price delivery order contract without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,361.39 delivery order is for the supply of 4567011755 Carvedilol ER 10 mg capsules, a cardiovascular medication. The contract has an ultimate completion date of January 23, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Carvedilol ER 80 mg capsules, with a ceiling value of $1,369.02 and a period of performance through August 2024. The contract is a delivery order type with a firm fixed price pricing structure. This award is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,920.00 firm-fixed-price delivery order is for the supply of Carvedilol ER 40 mg capsules, which are used to treat cardiovascular conditions. The contract has a completion date of May 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the provision of Carvedilol ER 40 mg capsules to the U.S. government. The contract, valued at $16,506.45, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award, valued at $2,980.77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 40 mg capsules, a cardiovascular medication, to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMHNG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4567199438 - Carvedilol ER 40 mg capsules in quantities of 30. The contract has a firm fixed price of $3,139.83 and an ultimate completion date of February 7, 2025. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 5/8/25, 9:45 AM